Dr. Reddy's Laboratories

And the results of 'Destination Dr. Reddy's' campus case study challenge are in! As part of the process, participants went through multiple rounds that tested their aptitude and functional knowledge through case studies, online assessments, and AI-based interviews. 111 participants were shortlisted from over 17,000 interested applicants from pharma, management and engineering colleges. The shortlisted teams then went through intense presentations, rigorous evaluations and sharp Q&A sessions in this two-day finale. Winning prizes were given away by our Co-Chairman and MD, Prasad G V and Global Head of Quality and Pharmacovigilance, Krishna Venkatesh. Prasad addressed questions from participants before announcing the winners. Congratulations to all the winners, runners-up and participants! And a huge shout-out to the cross-functional teams that enabled this exciting competition! Such industry-academia endeavours help us tap into bright young talent for solutions to build innovative healthcare models of the future ultimately benefiting patients, caregivers, healthcare professionals and other stakeholders. In turn, we try to offer an environment that helps them realise their full potential. Because indeed, great careers can't wait! #DrReddysAspire #GoodHealthCantWait #WeAreDrReddy

We’re at the two-day finale of the latest edition of our campus case study challenge, ‘Destination Dr. Reddy's – A Good Career Can't Wait’.   Following our call for registration, we received interest from over 17,000 students from across 1,000 management, engineering and pharma colleges in India. After three rounds of evaluation, we shortlisted the top 10 campus teams for the grand finale. The challenge? To create innovative solutions to specific real-life healthcare challenges, keeping patients at the heart of their endeavours.   Between today and tomorrow, 111 finale participants will go through orientation, interviews, deliver presentations, and present their case studies. The energy is high, and the participants are raring to go! We wish the teams the best and look forward to the future leaders of healthcare inspiring us with their fresh thinking and approach! Stay tuned!   #GoodHealthCantWait #DrReddysAspire #WeAreDrReddys

We're just two weeks away from #ESMO24! The European Society for Medical Oncology Congress is the most significant gathering to discuss cancer care innovation. Join us between September 13th-17th in Barcelona for #ESMO24. Visit our booth #649. We are keen to discuss our work in oncology, and learn about new ideas and potential for collaboration. See you in Barcelona! #GoodHealthCantWait #WeAreDrReddys #ESMO24 #Oncology

In PharmaSource's latest article, our CEO, Akhil Ravi, has shared an insightful look into why India is becoming a pivotal player in global biopharma outsourcing, how India’s 𝐜𝐨𝐦𝐦𝐢𝐭𝐦𝐞𝐧𝐭 𝐭𝐨 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐜𝐞, coupled with its 𝐜𝐨𝐬𝐭 𝐚𝐝𝐯𝐚𝐧𝐭𝐚𝐠𝐞𝐬 𝐚𝐧𝐝 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬, is creating a robust ecosystem for biopharma innovation.   Akhil has touched on the evolving landscape of R&D in India and how the country’s capabilities are expanding to meet the demands of a global market, with companies like Aurigene, having a 𝐬𝐭𝐫𝐨𝐧𝐠 𝐦𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐟𝐨𝐨𝐭𝐩𝐫𝐢𝐧𝐭 of our parent company, Dr. Reddy's Laboratories, are at the forefront of the growing global biopharma outsourcing trend.    Aurigene has been making aggressive capital investments in extending our RnD and GMP manufacturing capabilities, upgrading our existing labs and production lines, and expanding our manufacturing footprint with our 🏭 Recent operationalization of a 𝟳𝟬,𝟬𝟬𝟬 𝘀𝗾 𝗳𝘁 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝘀 𝗳𝗮𝗰𝗶𝗹𝗶𝘁𝘆, 🏭 𝟭𝟬𝟬% 𝗱𝗶𝗴𝗶𝘁𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗲𝗳𝗳𝗼𝗿𝘁𝘀, and  🏭 Sustainability goals of switching to 𝟭𝟬𝟬% 𝗿𝗲𝗻𝗲𝘄𝗮𝗯𝗹𝗲 𝗽𝗼𝘄𝗲𝗿 𝗯𝘆 𝟮𝟬𝟯𝟬   To read more on India's growing stature in the CDMO space and the contributions of companies like Aurigene in helping India's growth story, check out PharmaSource's article here - https://lnkd.in/etZg4TAj #CDMO #GrowthIndia #MakeInIndia #Pharma #DrugDevelopment #HealthCare

Proud of Team Dr. Reddy’s Thailand 🇹🇭 for serving 25k patients (Oncolgy & Nephrology) so far and counting. At Dr. Reddy’s we count our success in terms of patients we served. Accelerating access to Innovative and Affordable medicines because, #GoodHealthCantWait

Today, over 750 of our colleagues, including our Global Head of Quality and Pharmacovigilance, Krishna Venkatesh; our Chief Digital and Information Officer, Phani Mitra B; CEO of our CRDMO arm, Akhil Ravi; our CHRO, Archana Bhaskar and colleagues across business units came together to participate in the NMDC Hyderabad Marathon. Our participating colleagues were sponsored by our organisation in the 42 km, 21 km and 10 km categories. The run-up to the marathon saw over a month of training, tracking progress, sharing fitness journeys, fitness campaigns, and practice runs. As colleagues crossed the finish line one by one today, sharing their total run time with each other, and clicking pictures, it was a true celebration of the joy of running, fitness and camaraderie. Indeed, Good Health Can't Wait, and good health begins at home - through attention to our own fitness and health! #TeamworkIsDreamwork #WeAreDrReddys #HumansOfDrReddys #SDG3 (good health and well-being)

Just under three weeks to go for #ESMO24 ESMO - European Society for Medical Oncology! Our Europe and Emerging Markets teams will be present at the conference held from 13th-17th September in Spain. The event will have latest cutting-edge data, provide high-quality education and networking opportunities for oncologists and other stakeholders from all around the world. The conference is attended by more than 33,000 healthcare professionals (HCPs) every year. Visit our booth #649 at the ESMO 2024 in Barcelona, Spain. Stay tuned for more updates. #GoodHealthCantWait #WeAreDrReddys #ESMO24 #Oncology

With our India business team having just created a Guinness World Record for the largest brochure mosaic (logo) installation to create awareness of 'glycemic happiness', our Head of India Business, Sandeep Khandelwal, explains the context of the event. In India, approximately 42% of patients living with diabetes have high distress levels. Recent literature has reiterated the importance of happiness in improving health outcomes among people with diabetes. Our teams therefore worked with specialists on the concept of "glycemic happiness" and a glycemic happiness scale to measure it. It has been shared with over 7,500 healthcare professionals and benefited over 30,000 patients, with 88% specialists endorsing the importance of the glycemic happiness scale. The Guinness Record is not a one-time event for us, but our way of turning the spotlight on type 2 diabetes, the importance of its management through standard of care drugs accompanied by attention to psycho-social factors such as like glycemic happiness. #GoodHealthCantWait #GlycemicHappiness #WeAreDrReddys #Beyond100 #SDG3 (good health and well-being)

Pleased to share that our India business team has set a new Guinness World Record for the largest brochure mosaic (logo) installation standing at 162 square metres. This effort was undertaken by the team to shine a spotlight on a concept called "glycemic happiness" among people living with Type 2 diabetes. The installation is made up of feedback received from HCPs on glycemic happiness measurement.   India is often referred to as the diabetes capital of the world. Our efforts should be towards transforming India into a diabetes 'care' capital of the world. Attention to psycho-social factors has become important for a holistic approach to management of diabetes mellitus. Our team collaborated with endocrinologists and diabetologists on this concept of 'glycemic happiness'. Our aim is to create awareness among patients, healthcare professionals and caregivers about the importance of psycho-social wellbeing in the management of diabetes. Our team also created the 'Glycemic Happiness Scale' as an endeavour to measure 'glycemic happiness'. This was shared with over 7,500 HCPs, and has benefited over 30,000 patients. We are happy to share that an overwhelming majority of the HCPs who received the scale agreed that it was a useful initiative. In addition to our trusted diabetes portfolio, through this initiative, we aim to contribute to the enhancement of the current standard of care in diabetes management. #GoodHealthCantWait #GlycemicHappiness #WeAreDrReddys #Beyond100 #SDG3 (good health and well-being)